SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001214659-24-004498
Filing Date
2024-03-13
Accepted
2024-03-13 16:30:12
Documents
4
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 e313243pre14a.htm PRE 14A 503773
2 GRAPHIC alzamendlogo_regmark.jpg GRAPHIC 17222
3 GRAPHIC compchart_totalsharereturn.jpg GRAPHIC 78488
4 GRAPHIC compchart_netloss.jpg GRAPHIC 72495
  Complete submission text file 0001214659-24-004498.txt   736948
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: PRE 14A | Act: 34 | File No.: 001-40483 | Film No.: 24746351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)